KEILAR: Shares of Kodak plummeting on the New York Stock Exchange today, down some 40 percent at one point, after an almost $800 million federal loan to make drug ingredients was put on hold. CNN's Alison Kosik is in New York. And, Alison, there are several layers to the story. Tell us what investors are reacting to, exactly.</s>ALISON KOSIK, CNN BUSINESS CORRESPONDENT: Brianna, we're seeing investors kind of rattled about regulators blocking that $765 million loan to Kodak because they're investigating allegations of insider trading and investigating how the company got this government loan in the first place to make drug ingredients for generics. Now when this announcement was made late last month, we saw shares soar more than 2,000 percent over two days. So this stock has been on a wild ride. And remember, this company, Kodak, has fallen off the radar since being an innovator in making that Kodak moment synonymous with taking a picture. So we haven't heard of Kodak for a very long time. And to see the price spikes raised some eyebrows on Wall Street. So now there are questions about the executives, about the chief executive and CEO, about why he received stock options a day before this loan announcement. Also, the Securities and Exchange Commission is going to be investigating the timing of this announcement. It wants to know why Kodak announced through a media advisory that this loan deal went through a day before it made the official announcement. Now Kodak did provide a statement to CNN saying it did not intend to make those details public on a local TV station in Kodak's hometown of Rochester, New York. But I want to point out this is an unusual deal with the government that leverages the Defense Production Act, which gives the government power to direct certain kinds of production in the name of national security. And the Trump administration spoke very highly of this deal, though then -- President Trump specifically.
Kodak Stock Plummets After Government Loan Put On Hold.